Evidence map›Paper›PMID 20538985›Full record

Trial reportInvestigative ophthalmology & visual science2010

Risk factors for corneal infiltrative events during continuous wear of silicone hydrogel contact lenses.

Loretta Szczotka-Flynn, Jonathan H Lass, Ajay Sethi, Sara Debanne, Beth Ann Benetz, Matthew Albright, Beth Gillespie, Jana Kuo, Michael R Jacobs, Alfred Rimm

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Investigative ophthalmology & visual science, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00727402 (The Longitudinal Evaluation of Silicone Hydrogel), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00727402 completednot on this map

The Longitudinal Evaluation of Silicone Hydrogel (LASH) Contact Lens Study

TypeobservationalSponsorNational Eye Institute (NEI)Ran2006 to 2009Enrolled205ConditionsCorneal Infiltrates
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Comparative Evaluation ofVision (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Antibacterial Activities of Lipopeptide (CInternational journal of molecular sciences · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. DEBS - a unification theory for dry eye and blepharitis.Clinical ophthalmology (Auckland, N.Z.) · 2016
    Article
  17. Article
  18. Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118).Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2013
    Article
  19. Tear cytokine response to multipurpose solutions for contact lenses.Clinical ophthalmology (Auckland, N.Z.) · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Loretta Szczotka-FlynnDepartment of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, Ohio 44106, USA. loretta.szczotka@uhhospitals.org
Jonathan H Lass
Ajay Sethi
Sara Debanne
Beth Ann Benetz
Matthew Albright
Beth Gillespie
Jana Kuo
Michael R Jacobs
Alfred Rimm
Case Western Reserve University · USUniversity of Wisconsin–Madison · US

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Paul S Park · 1997 to 2026
$17.7M
Longitudinal Analysis of Silicone Hydrogel (LASH) StudyK23EY015270 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI SZCZOTKA-FLYNN, LORETTA B · 2004 to 2008
$899k
NEI NIH HHS K23 EY015270NEI NIH HHS K23EY015270-01NEI NIH HHS P30 EY011373NEI NIH HHS P30EY11373
6 · The paper itself

Abstract

purposeThis study determined which microbiologic, clinical, demographic, and behavioral factors are associated with corneal infiltrative events (CIEs) during continuous wear of silicone hydrogel (SH) contact lenses.

methodsSubjects (n = 205) were fitted with lotrafilcon A lenses for continuous wear and observed for 1 year. The main exposures of interest were corneal staining and bacterial lens contamination. Kaplan-Meier (KM) plots were used to estimate the cumulative unadjusted probability of remaining CIE free, and Cox proportional hazards regression was used to model the hazard of having a CIE, as a function of key predictor variables.

resultsThe KM-unadjusted cumulative probability of remaining CIE free was 73.3%. Approximately 53% of subjects had repeated episodes of corneal staining (mild or greater), and 11.3% had repeated episodes of moderate or greater corneal staining. Corneal staining was not associated with the development of a CIE. The frequency of substantial bacterial bioburden on worn lenses at the time of a CIE was 64.7%, compared with only 12.2% during uncomplicated wear. The presence of substantial lens bacterial bioburden was associated with the development of a CIE (adjusted hazards ratio [HR], 8.66; 95% confidence interval [CI], 2.88-26.01). Smoking was also associated with a CIE (adjusted HR, 4.13; 95% CI, 1.27-13.45).

conclusionsCorneal staining is common during continuous wear of SH lenses, but it is not associated with the development of a CIE. Smoking and substantial lens bacterial bioburden pose prominent risks of a CIE. In this study, more than 70% of the total risk of CIE in those with substantial lens bioburden is attributable to this exposure. (ClinicalTrials.gov number, NCT00727402).

Indexed as

HydrogelsSiliconesAdolescentAdultBacteriaBacterial AdhesionContact Lenses, HydrophilicCorneal UlcerFemaleFluorocarbonsFluorophotometryFollow-Up StudiesHumansMaleMiddle AgedModels, StatisticalFluorocarbonsHydrogelslotrafilcon ASilicones

Identifiers

PMID20538985
PMCPMC3061493
OpenAlexW1981947740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.